Welcome to LookChem.com Sign In|Join Free
  • or
Methyl 2-bromo-6-methoxybenzoate is an organic compound that features a benzoate structure with a bromine atom at the 2nd position, a methoxy group at the 6th position, and a methyl ester functional group. It is known for its unique chemical properties and reactivity, which make it a valuable intermediate in the synthesis of various organic compounds.

31786-46-6

Post Buying Request

31786-46-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

31786-46-6 Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-bromo-6-methoxybenzoate is used as a reactant for the synthesis of orchid pigments, specifically dengibsin and dengibsinin. These pigments are of interest due to their potential applications in the pharmaceutical industry, possibly for the development of novel drugs or as markers in biological research.
Used in Chemical Synthesis:
Methyl 2-bromo-6-methoxybenzoate is used as an intermediate in the synthesis of various organic compounds, particularly those with potential applications in the pharmaceutical, agrochemical, and materials science industries. Its unique structure and reactivity make it a versatile building block for the creation of new molecules with specific properties and functions.

Check Digit Verification of cas no

The CAS Registry Mumber 31786-46-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,7,8 and 6 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 31786-46:
(7*3)+(6*1)+(5*7)+(4*8)+(3*6)+(2*4)+(1*6)=126
126 % 10 = 6
So 31786-46-6 is a valid CAS Registry Number.

31786-46-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 2-bromo-6-methoxybenzoate

1.2 Other means of identification

Product number -
Other names methyl 2-bromo-6-methoxy-benzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:31786-46-6 SDS

31786-46-6Relevant academic research and scientific papers

N,B-bidentate boryl ligand-supported iridium catalyst for efficient functional-group-directed C-H borylation

Wang, Guanghui,Liu, Li,Wang, Hong,Ding, You-Song,Zhou, Jing,Mao, Shuai,Li, Pengfei

, p. 91 - 94 (2017/05/16)

Convenient silylborane precursors for introducing N,B-bidentate boryl ligands onto transition metals were designed, prepared, and employed in ready formation of irdium(IIl) complexes via Si-B oxidative addition. A practical, efficient catalytic ortho-borylation reaction of arenes with a broad range of directing groups was developed using an in situ generated catalyst from the silylborane preligand 3c and [IrCl(COD)]2.

Selenium-catalyzed C(sp3)-H acyloxylation: Application in the expedient synthesis of isobenzofuranones

Kr?tzschmar, Felix,Kassel, Martin,Delony, Daniel,Breder, Alexander

supporting information, p. 7030 - 7034 (2015/05/05)

Oxidative Se-catalyzed C(sp3)-H bond acyloxylation has been used to construct a diverse array of isobenzofuranones from simple ortho-allyl benzoic acid derivatives. The synthetic procedure employs mild reaction conditions and gives high chemoselectivity enabled by an inexpensive organodiselane catalyst. The presented approach offers a new synthetic pathway toward the core structures of phthalide natural products.

PYRIDINYL AND FUSED PYRIDINYL TRIAZOLONE DERIVATIVES

-

Paragraph 0250-0252, (2014/09/29)

Disclosed are compounds of Formula 1, or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating Type I hypersensitivity reactions, autoimmune diseases, inflammatory disorders, cancer, non-malignant proliferative disorders, and other conditions associated with BTK.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 31786-46-6